BIVDA Press Releases

FluoretiQ Ltd. today announced the appointment of Mr Kasra Saeb-Parsy Consultant Urologist with Cambridge (UK) University Hospitals NHS Foundation Trust as their Chief Medical Officer. Mr. Saeb-Parsy will oversee and lead all clinical development, regulatory and medical affairs strategies and activities of the Company."I am delighted to welcome Kasra as our Chief Medical Officer at this key stage of our company growth as we approach clinical studies and regulatory approval in the UK and USA...

BIVDA welcomes NICE Five Year Plan BIVDA, the trade association for British IVD companies,  has welcomed the publication of NICE’s five year strategy document. The document runs from 2021 to 2026 and is designed to ensure the organisation remains “excellent”, more dynamic and more collaborative in their work. According to NICE,  the plan puts science and evidence at the heart of health and care decision making, while keeping ahead of the challenges of a rapidly c...

BIVDA, the trade association for British in-vitro diagnostic companies, has welcomed the launch of the ‘Medicines and Diagnostics Manufacturing Transformation Fund’ which is now open for applications. The new fund of £20 million is dedicated to expanding the manufacturing capacity of the life sciences industry.  The fund is open to manufacturers of human licensed medicines, medical diagnostics and medical devices, and projects must have a minimum total size of 8M, wit...

BIVDA launches the Don’t Wait;Act Testing Campaign For Immediate Release  -- BIVDA, the trade association for British in-vitro diagnostic companies, has launched its new Don’t Wait;Act campaign to re-start testing for non-COVID health issues today. Routine care and health screening for diseases such as cancers, heart disease and diabetes have either experienced long pauses or drops in take-ups from members of the public during the COVID-19 pandemic. As a result, t...

BIVDA welcomes new Government research strategy BIVDA, the trade association for British in-vitro diagnostic companies, has welcomed the publication of the Government’s new research strategy ‘Saving and improving lives: the future of UK clinical research delivery’. The strategy sets out plans to strengthen the UK’s renowned expertise as a world-leader in designing and delivering medical and scientific research. It is built around 5 key themes:  Clinical research...

BIVDA Welcomes new EUCOPE – Charles River Associates report on advanced diagnostics  BIVDA, the UK trade association for in-vitro diagnostic companies, has welcomed the publication of a White Paper on Advanced Diagnostics by EUCOPE and Charles River Associates that puts forward concrete proposals to support understanding of the advanced diagnostics sector, the benefits it brings and related requirements for success . The health benefits of genomics and advanced genomic testing ar...

MICROSENSDX RapiPRO™ LAMP for SARS-CoV-2 RECEIVES CE MARK APPROVAL Pioneering British biotech MicrosensDx has announced that its RapiPRO™ LAMP SARS-CoV-2 test has received CE Certification.The business, an established molecular diagnostics innovator with a 20-year history in IVD development, is a recognised expert in Loop-mediated Isothermal Amplification (LAMP) testing, having developed proprietary tuberculosis (TB) diagnostics using the technology.MicrosensDx has revealed robu...

PulmoBioMed – a new medtech spin-out in the North East of England Launched with funding from Northumbria University and Innovate UK, and with its first product PBM-HaleTM in clinical trials in Europe, PulmoBioMed now seeks to close its £2.5 m initial equity capital raise. PBM-HaleTM, a Class 1 medical device, is designed to collect exhaled breath condensate samples in a non-invasive manner. The hand-held device captures a wide range of biomarkers including protein, RNA, DNA...

Microsemi CRP LC-767G HORIBA Medical, specialists in automated in vitro diagnostic systems for haematology, haemostasis and clinical chemistry analysis, has obtained the CE Mark certification for its new generation of the Microsemi CRP haematology analyser, the Microsemi CRP LC-767G. This new generation analyser Microsemi CRP LC-767G is more compact and proposes enhanced software and network connectivity providing higher memory, usability plus a new parameter: Granulocytes-to- Lymphocy...

Press Release - BIVDA Comments on Budget 2021 support for life sciences  BIVDA, the trade association for British in-vitro diagnostic companies, has commented on today’s Budget announcements, outlined in the House of Commons by Chancellor Rishi Sunak.  The British IVD industry is a growing and innovative part of our economy. This Budget, coming as the health service and our economy begin to recover from the effects of the COVID-19 pandemic, offers an opportunity to ensure the IVD...